GRIN1: Glutamate Ionotropic Receptor NMDA Type Subunit 1

Essential subunit of the NMDA receptor, critical for synaptic plasticity and implicated in neurodevelopmental disorders

Gene Information Card

Symbol GRIN1
Full Name Glutamate Ionotropic Receptor NMDA Type Subunit 1
Gene Type Protein coding
Chromosomal Location 9q34.3
NCBI Gene ID 2902 ncbi.nlm.nih.gov/gene/2902
Ensembl ID ENSG00000176884
UniProt ID Q05586
OMIM ID 138249
HGNC ID 4584
Aliases NMDAR1, NR1, GluN1, MRD8, DEE101

Description

GRIN1 encodes the GluN1 subunit of the N-methyl-D-aspartate (NMDA) receptor, a ligand-gated ion channel that mediates excitatory neurotransmission. The GluN1 subunit is essential for receptor assembly and function, forming heterotetrameric complexes with GluN2 or GluN3 subunits. GRIN1 is critical for synaptic plasticity, learning, and memory. Pathogenic variants in GRIN1 are associated with neurodevelopmental disorders including intellectual disability, epilepsy, and developmental and epileptic encephalopathy.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Developmental and epileptic encephalopathy 101 (DEE101) Loss-of-function or gain-of-function variants impair NMDA receptor activity, leading to neuronal hyperexcitability or hypoexcitability ClinVar, OMIM
Intellectual disability, autosomal dominant 8 (MRD8) Missense variants disrupt receptor function, affecting synaptic transmission and plasticity OMIM, PubMed
Epilepsy, focal, with speech disorder and with or without intellectual disability GRIN1 variants alter channel gating or ion permeability, contributing to seizure susceptibility ClinVar, OMIM

Expression Profile

Tissue Expression
Tissue nTPM level
Cerebral cortex 12.5 High
Hippocampus 15.2 High
Cerebellum 8.3 Medium
Spinal cord 4.1 Low
Testis 1.2 Not detected
Cell Line Expression
Cell Line nTPM Notes
SH-SY5Y (neuroblastoma) 10.8 High expression
U-87 MG (glioblastoma) 6.5 Moderate expression
HEK293 (embryonic kidney) 0.3 Low/not detected
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1636C>T (p.Arg546Trp) Missense Rare Gain-of-function; increased calcium influx, associated with DEE101
c.1915G>A (p.Val639Met) Missense Rare Loss-of-function; reduced channel activity, linked to intellectual disability
c.2440G>A (p.Gly814Arg) Missense Rare Dominant-negative; impairs receptor trafficking, associated with epilepsy
Mutation functional classification

Loss of Function (LOF)

Variants that reduce NMDA receptor current or surface expression, e.g., p.Val639Met, leading to hypoexcitability and intellectual disability.

Gain of Function (GOF)

Variants that increase channel open probability or calcium permeability, e.g., p.Arg546Trp, causing hyperexcitability and epileptic encephalopathy.

Dominant Negative (DN)

Variants that interfere with wild-type subunit assembly or trafficking, e.g., p.Gly814Arg, resulting in reduced functional receptors.

Pathways

UniProt: hsa04724 – Glutamatergic synapse
UniProt: hsa05030 – Cocaine addiction
UniProt: hsa05031 – Amphetamine addiction
UniProt: hsa05032 – Morphine addiction
UniProt: hsa05033 – Nicotine addiction

Protein Summary

The GluN1 protein (UniProt Q05586) is a 938-amino acid transmembrane subunit of the NMDA receptor. It contains an extracellular N-terminal domain, a ligand-binding domain for glycine, three transmembrane helices (M1, M3, M4), a re-entrant pore loop (M2), and an intracellular C-terminal domain. GluN1 is essential for receptor assembly and ion channel function. Alternative splicing generates multiple isoforms with distinct C-terminal tails, modulating receptor trafficking and signaling.

Related Products

Product name Cat.No. Species Gene ID
GRIN1 Knockout HEK293 Cell Line EDJ-KQ1219 Human 2902 Details Get a Quote
GRIN1 Knockout HCT 116 Cell Line EDJ-KQ20548 Human 2902 Details Get a Quote
GRIN1 Knockout HeLa Cell Line EDJ-KQ53429 Human 2902 Details Get a Quote
GRIN1 Knockout A-549 Cell Line EDJ-KQ61905 Human 2902 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: